Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Outset Medical, Inc.OM · Entity 7026 | Chief Operating Officer | March 01, 2023 | March 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Outset Medical, Inc.
Report date March 01, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,112 |
Reported balance
After 2023-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-03-01 · Exercise / conversion · Acquired 5,000 · Balance 108,112 |
| Common StockSEC Table I · non-derivative | Direct | 103,112 |
Reported balance
After 2023-03-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-03-01 · Sale · Disposed 5,000 · Balance 103,112 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. F3: Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c). |
| Performance Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.88 · Expires 2027-12-19 | Direct | 43,507 |
Reported balance
After 2023-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-01 · Exercise / conversion · Disposed 5,000 · Balance 43,507 F4: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F2: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.
F3: Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).
F4: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 2, 2023 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-23-000027 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,507 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $22.33 | $111,650.50 |
DisclosureSEC source: 0001484612-23-000027 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,112 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. F3 · balance_after: Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-23-000027 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2023 Filed Feb 16, 2023 20:38 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,667 | $24.36 | $40,608.12 |
DisclosureSEC source: 0001484612-23-000020 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,504 F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 3,257 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 16, 2023 Filed Feb 16, 2023 20:38 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 264 | $24.37 | $6,433.68 |
DisclosureSEC source: 0001484612-23-000020 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,171 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 516 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 6,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · derivative · entry 12 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,507 Underlying: Common Stock · 6,500 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 6,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · derivative · entry 11 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,007 Underlying: Common Stock · 6,500 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 6,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · derivative · entry 10 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,507 Underlying: Common Stock · 6,500 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,500 | $30.00 | $195,000.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 8 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,435 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,500 | $3.88 | $25,220.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 7 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,500 | $30.00 | $195,000.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,435 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,500 | $3.88 | $25,220.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,500 | $30.00 | $195,000.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,435 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| February 02, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,500 | $3.88 | $25,220.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · derivative · entry 9 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| February 01, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $27.91 | $139,553.50 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,435 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $27.00 - $27.99 - 3,640 shares; $28.00 - $28.99 - 1,360 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Mar 2, 2023 18:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 16:47 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 4,674 | $27.92 | $130,498.08 |
DisclosureSEC source: 0001484612-23-000015 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,435 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 13,023 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 16:53 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 3,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000005 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,109 F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 16:53 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 56,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000005 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,924 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-23-000002 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $26.14 | $130,716.00 |
DisclosureSEC source: 0001484612-23-000002 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,290 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $25.00 - $25.99 - 1,991 shares; $26.00 - $26.99 - 3,009 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-23-000002 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 18:14 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000083 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 18:14 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $20.85 | $104,250.00 |
DisclosureSEC source: 0001484612-22-000083 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,290 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 18:14 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-22-000083 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 16:18 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 260 | $19.29 | $5,015.40 |
DisclosureSEC source: 0001484612-22-000075 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,290 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 516 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 370 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · derivative · entry 12 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,007 Underlying: Common Stock · 370 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 4,630 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · derivative · entry 11 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,377 Underlying: Common Stock · 4,630 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · derivative · entry 10 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · derivative · entry 9 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 370 | $20.00 | $7,400.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 8 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,550 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 370 | $3.88 | $1,435.60 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 7 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 4,630 | $20.00 | $92,600.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,550 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 4,630 | $3.88 | $17,964.40 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,550 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,550 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 19:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 573 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2022 to August 31, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| August 16, 2022 Filed Aug 16, 2022 18:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 260 | $21.48 | $5,584.80 |
DisclosureSEC source: 0001484612-22-000067 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,977 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 516 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:14 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000060 · edgardoc.xml · derivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:14 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000060 · edgardoc.xml · derivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:14 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001484612-22-000060 · edgardoc.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,237 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:14 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-22-000060 · edgardoc.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:14 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001484612-22-000060 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,237 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:14 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-22-000060 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 16:30 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000054 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 16:30 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $21.42 | $107,081.50 |
DisclosureSEC source: 0001484612-22-000054 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,237 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 509 shares; $21.00-$22.99 - 4,286 shares; $23.00-$23.99 - 205 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 16:30 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-22-000054 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2022 Filed May 17, 2022 19:04 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 258 | $26.36 | $6,800.88 |
DisclosureSEC source: 0001484612-22-000042 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,237 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 516 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.